Properties, production, and applications of camelid single-domain antibody fragments

被引:587
作者
Harmsen, M. M.
De Haard, H. J.
机构
[1] Univ Wageningen & Res Ctr, Inst Anim Sci & Hlth, NL-8219 PH Lelystad, Netherlands
[2] Ablynx NV, B-9052 Ghent, Belgium
关键词
single-domain; microbial production; yeast; glycosylation;
D O I
10.1007/s00253-007-1142-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain is fully capable of antigen binding. These single-domain antibody fragments (VHHs or Nanobodies (R)) have several advantages for biotechnological applications. They are well expressed in microorganisms and have a high stability and solubility. Furthermore, they are well suited for construction of larger molecules and selection systems such as phage, yeast, or ribosome display. This minireview offers an overview of (1) their properties as compared to conventional antibodies, (2) their production in microorganisms, with a focus on yeasts, and (3) their therapeutic applications.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 93 条
  • [1] Generation of llama single-domain antibodies against methotrexate, a prototypical hapten
    Alvarez-Rueda, Nidia
    Behar, Ghislaine
    Ferre, Virginie
    Pugniere, Martine
    Roquet, Francoise
    Gastinel, Louis
    Jacquot, Catherine
    Aubry, Jacques
    Baty, Daniel
    Barbet, Jacques
    Birkle, Stephane
    [J]. MOLECULAR IMMUNOLOGY, 2007, 44 (07) : 1680 - 1690
  • [2] Prokaryotic expression of antibodies
    Arbabi-Ghahroudi, M
    Tanha, J
    MacKenzie, R
    [J]. CANCER AND METASTASIS REVIEWS, 2005, 24 (04) : 501 - 519
  • [3] Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
    Baral, Toya Nath
    Magez, Stefan
    Stijlemans, Benoit
    Conrath, Katja
    Vanhollebeke, Benoit
    Pays, Etienne
    Muyldermans, Serge
    De Baetselier, Patrick
    [J]. NATURE MEDICINE, 2006, 12 (05) : 580 - 584
  • [4] Contributions of CDR3 to VHH domain stability and the design of monobody scaffolds for naive antibody libraries
    Bond, CJ
    Marsters, JC
    Sidhu, SS
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 332 (03) : 643 - 655
  • [5] Antigen binding and solubility effects upon veneering of a camel VHH in framework-2 to the mimic a VH
    Conrath, K
    Vincke, C
    Stijlemans, B
    Schymkowitz, J
    Decanniere, K
    Wyns, L
    Muyldermans, S
    Loris, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 350 (01) : 112 - 125
  • [6] β-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae
    Conrath, KE
    Lauwereys, M
    Galleni, M
    Matagne, A
    Frère, JM
    Kinne, J
    Wyns, L
    Muyldermans, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) : 2807 - 2812
  • [7] Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs
    Conrath, KE
    Lauwereys, M
    Wyns, L
    Muyldermans, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7346 - 7350
  • [8] Formatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
    Coppieters, Ken
    Dreier, Torsten
    Silence, Karen
    de Haard, Hans
    Lauwereys, Marc
    Casteels, Peter
    Beirnaert, Els
    Jonckheere, Heidi
    de Wiele, Christophe Van
    Staelens, Ludovicus
    Hostens, Jeroen
    Revets, Hilde
    Remaut, Erik
    Elewaut, Dirk
    Rottiers, Pieter
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (06): : 1856 - 1866
  • [9] Efficient cancer therapy with a nanobody-based conjugate
    Cortez-Retamozo, V
    Backmann, N
    Senter, PD
    Wernery, U
    De Baetselier, P
    Muyldermans, S
    Revets, H
    [J]. CANCER RESEARCH, 2004, 64 (08) : 2853 - 2857
  • [10] Efficient tumor targeting by single-domain antibody fragments of camels
    Cortez-Retamozo, V
    Lauwereys, M
    Gh, GH
    Gobert, M
    Conrath, K
    Muyldermans, S
    De Baetselier, P
    Revets, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) : 456 - 462